PMTC 2013 - 1st International Conference of Personalized Medicine and Targeted Therapies in Cancer

Website pmtc2013.com/index.html | Edit Freely

Category PMTC 2013

Deadline: October 15, 2012 | Date: January 31, 2013-February 02, 2013

Venue/Country: Sharjah, United Arab Emirates

Updated: 2012-07-04 22:52:40 (GMT+9)

Call For Papers - CFP

Organized by the Sharjah Research Academy, in collaboration with Sharjah University and the Institute Gustave-Roussy, the event will highlight and discuss hot topics of targeted anti-cancer therapies being utilized and developed in the region and worldwide, and current updates on Personalized Medicine, addressing improvements in diagnosing diseases, increasing the safety of drugs and identifying future treatments to enhance patient care.

Conference Dates: 31 January - 2 February 2013

Organiser: Sharjah Research Academy

In collaboration with: University of Sharjah and Institute Gustave Roussy

Venue: Sharjah Medical Excellence Cluster

Conference Highlights

Comprehensive scientific program with a broad range of subspecialties and topic areas

Distinguished panel of leading experts from the field

Workshops and Courses

Abstract submission for oral and poster presentations

Program Topics

Tumor progression: basic and therapeutic aspects

Cancer biomarkers

Aberrant signaling pathways in malignancy

Novel targeted therapy in cancer

Chemotherapy resistance

Pharmacogenomics, personalized diagnostics and medicine

Genome project on drug development and cancer therapy

Epigenetics and its impact on cancer therapy

Who Should Attend?

We warmly invite researchers from academia and industry, clinicians, oncologists, students, health managers, and health care personnel practicing oncology in all disciplines of oncology for their participation at this first conference in the Gulf region. We encourage them to contribute to this important exchange and to identify key advances in this field that is revolutionizing the medical world and holds the potential to greatly improve patient care. Stakeholders among government and decision makers are also invited.

Why Attend?

By attending PMTC2013, attendees will have the opportunity to:

Access some of the most respected and renowned medical professionals in the field of personalized medicine and targeted therapies in cancer

Network with a truly international audience, from several subspecialties

Free access to the exhibition running alongside the conference, and gain insight to the latest product information and trends

Enhance medical knowledge and practice through the rich resources available